A National Study of the Chronic Disease Self-Management Program

NCT01845857 | Completed

• 2 other identifiers: SU-07212010-658518933 IRB Protocol
• Study Type: interventional
• Target: 1,170
• Locations: 1 country
• Sites: 1

Brief Summary

This survey will address important research, practice, and policy questions: How does Chronic Disease Self-Management Program (CDSMP) impact participants' general health, their health behaviors, and their need for health care utilization? Who benefits most from the CDSMP program? Are predicted gains maintained over a six and twelve month period? Can critical clinical changes be seen for those who are diabetic?

Conditions

Diabetes Mellitus, Type 2; Chronic Disease

Keywords

Long term health problems; chronic disease

Outcome Measures

Primary Outcomes (2)

• Change in Health Status (symptoms, activities limitations)

  Baseline to 6 months

• Change in Health Status (symptoms, activities limitations)

  baseline to 12 months

Secondary Outcomes (8)

• Change in Health behaviors (exercise, medical adherence)

  baseline to 6 months

• Change in health related quality of life

  baseline to 6 months

• Change in Metabolic control (HbA1c for type 2 diabetics)

  baseline to 6 months

• Change in Health Care Utilization

  baseline to 6 months

• Change in Health behaviors (exercise, medical adherence)

  baseline to 12 months

Study Arms (1)

Chronic Disease Self-Management Workshop

EXPERIMENTAL

Longitudinal study of participants who take the CDSMP workshop

Behavioral: Chronic Disease Self-Management Workshop

Interventions

Chronic Disease Self-Management Workshop BEHAVIORAL

6 week, small group self-management workshop

Chronic Disease Self-Management Workshop

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Age 18 or over
• Has a chronic health condition
• Attending a Chronic Disease Self-Management Workshop at a designated host site in the United states
• Speaks English or Spanish
• For blood test portion of study: have type 2 diabetes

Sponsors & Collaborators

• Stanford University: lead

Study Sites (1)

Stanford University School of Medicine

Stanford, California, 94305, United States

Location

Related Publications (2)

• Lorig KR, Ritter P, Stewart AL, Sobel DS, Brown BW Jr, Bandura A, Gonzalez VM, Laurent DD, Holman HR. Chronic disease self-management program: 2-year health status and health care utilization outcomes. Med Care. 2001 Nov;39(11):1217-23. doi: 10.1097/00005650-200111000-00008.

  PMID: 11606875 BACKGROUND

• Lorig KR, Ritter PL, Gonzalez VM. Hispanic chronic disease self-management: a randomized community-based outcome trial. Nurs Res. 2003 Nov-Dec;52(6):361-9. doi: 10.1097/00006199-200311000-00003.

  PMID: 14639082 BACKGROUND

MeSH Terms

Conditions

Diabetes Mellitus, Type 2; Chronic Disease

Condition Hierarchy (Ancestors)

Diabetes Mellitus; Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Kate R Lorig

  Stanford University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: professor emertius

Study Record Dates

• First Submitted: August 9, 2010
• First Posted: May 3, 2013
• Study Start: August 1, 2010
• Primary Completion: April 1, 2011
• Study Completion: April 1, 2013
• Last Updated: May 3, 2013

Record last verified: 2010-08

Locations

US (1)